Paid kidney cancer research studies

Yes. Every MediTalk research study , including those focused on kidney cancer , offers compensation for your time. Payment varies by study format and length, and is shown on each study's listing before you express interest.

Anyone diagnosed with kidney cancer (and in some studies, family members or caregivers of someone with kidney cancer) can register their interest. Each study has its own eligibility criteria (age, country, treatment history) shown on its listing , so you only spend time on studies you're actually a fit for.

Most MediTalk kidney cancer studies are remote and run on Zoom or a similar video platform , one-to-one interviews, focus groups or online surveys. Time commitment is shown on each listing (typically 30-90 minutes). You only need a quiet space, a webcam and a stable internet connection.

Yes. MediTalk is a UK-registered healthcare market-research platform run by Medicys Ltd, and all submissions are handled under UK GDPR. Your name and contact details are never shared with study sponsors , only de-identified research insights are reported back.

Register your interest anyway , registration takes about two minutes, and you'll be the first to hear when a new kidney cancer study opens. We typically launch new studies every few weeks across many conditions.